SR&ED in 2026: What Canadian Innovators Keep Leaving on the Table

Ask a room of Canadian founders whether their company does research and development, and most software and manufacturing leaders will say no — they're just solving hard problems for customers. Ask the Income Tax Act, and a substantial share of that same work is Scientific Research and Experimental Development, eligible for investment tax credits that can return 35 cents or more on every qualifying dollar for Canadian-controlled private corporations.

The three ways value is left behind

First, non-filers: companies that assume SR&ED means laboratories and white coats, when the program's centre of gravity is experimental development — the systematic resolution of technological uncertainty in ordinary commercial work. Second, under-claimers: companies that file, but scope claims narrowly to feel safe, omitting supporting work, failed experiments, and eligible overheads. Third, fragile claimers: companies whose claims are directionally right but documented so thinly that a review becomes a negotiation from weakness.

What reviewers actually look for

The CRA's framework is unglamorous and learnable: technological uncertainty, systematic investigation, and technological advancement, evidenced contemporaneously. Claims fail not because the work wasn't eligible but because the narrative was written twelve months later by someone who wasn't in the room, with costs allocated by guesswork. The fix is procedural, not heroic — light-touch documentation habits that engineering teams will actually follow.

Beyond SR&ED

SR&ED is the anchor, not the whole strategy. IRAP contributions, provincial credits, digital adoption programs, and sector funds frequently stack with a well-planned claim. Companies that treat government funding as an annual scramble capture a fraction of what a planned, calendar-driven approach yields — often the difference between funding one project and funding a roadmap.

A note on fees and incentives

The contingency-fee segment of the SR&ED industry has earned its reputation for maximizing claims rather than defensible claims. Whatever advisor you choose, insist on two things: review defence included in the fee, and a documentation system that makes next year's claim stronger than this year's. If the pitch is 'free money, no effort,' the risk has simply been moved onto your file.

Talk to the team behind the thinking. If this article describes your situation, a working conversation with a Meravon partner costs nothing and commits you to nothing. Book an executive consultation.